- Trials with a EudraCT protocol (1,212)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
1,212 result(s) found for: Bone Metastases.
Displaying page 1 of 61.
EudraCT Number: 2010-018491-24 | Sponsor Protocol Number: 31295 | Start Date*: 2010-07-15 | |||||||||||
Sponsor Name:Vrije Universiteit Medical Center | |||||||||||||
Full Title: Effect of aminobisphosphonates and statins on circulating Vy9Vd2-T cells | |||||||||||||
Medical condition: patients with malignant bone metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009374-27 | Sponsor Protocol Number: 20080540 | Start Date*: 2009-08-27 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab in the Treatment of Bone Metastases in Subjects with Advanced Cancer or Multiple Myeloma | |||||||||||||
Medical condition: Bone metastases in subjects with advanced cancer or multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004942-15 | Sponsor Protocol Number: CZOL446EIT14 | Start Date*: 2005-12-15 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: A prospective, randomized, multi-center comparative 2-arm trial on efficacy and safety of zoledronic acid every 3-months vs. every 4 weeks beyond approximately 1 year of treatment with zoledronic... | |||||||||||||
Medical condition: bone metastasis in patients with breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024624-20 | Sponsor Protocol Number: OCRD2010/22 | Start Date*: 2011-07-12 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | ||
Full Title: A Pilot Study Investigating the Sensitivity of 18F-labelled Sodium Fluoride PET-CT for Detecting Skeletal Metastases in Renal Cell Carcinoma compared to Planar Bone Scintigraphy and Multidetector CT | ||
Medical condition: Metastatic renal cell carcinoma. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-000848-65 | Sponsor Protocol Number: 20050244 | Start Date*: 2006-09-01 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects with Advanced Cancer (Excluding Breast and Prostate... | |||||||||||||
Medical condition: Treatment of bone metastases in subjects with advanced cancer (excluding breast and prostate cancer) or multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Completed) PT (Completed) AT (Completed) NL (Completed) BE (Completed) HU (Completed) GB (Completed) LT (Completed) DE (Completed) SK (Completed) LV (Completed) SE (Completed) IT (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012189-30 | Sponsor Protocol Number: BC1-09 | Start Date*: 2009-10-30 | |||||||||||
Sponsor Name:Algeta ASA | |||||||||||||
Full Title: An open-label Phase IIa, non-randomised, study of Alpharadin in breast cancer patients with bone dominant disease who are no longer considered suitable for endocrine therapy | |||||||||||||
Medical condition: Breast cancer patients with bone dominant disease who have progressed on endocrine therapy and are no longer considered suitable for further endocrine therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-018044-18 | Sponsor Protocol Number: TaxiumII | Start Date*: 2012-06-22 | ||||||||||||||||
Sponsor Name:Meander MC | ||||||||||||||||||
Full Title: A randomised phase II study of repeated Rhenium-188 HEDP combined with Docetaxel versus Docetaxel alone in castration resistant prostate cancer (CRPC) metastatic to bone’ | ||||||||||||||||||
Medical condition: Men with castration resistant prostate cancer (CRPC) metastatic to bone | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005327-41 | Sponsor Protocol Number: INT0211 | Start Date*: 2012-04-05 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: Clinical trial randomized and controlled to compare the analgesic efficacy of the association zoledronic acid and 153Sm-lexidronam vs zoledronic acid in patients with skeletal metastases from hormo... | |||||||||||||
Medical condition: Population enrolled in the study is represented by patients bearing advanced prostatic cancer with skeletal metastases and bone pain cancer-associated and treated with analgesic drugs | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002120-29 | Sponsor Protocol Number: 0822-030 | Start Date*: 2008-08-13 | |||||||||||
Sponsor Name:Merck&Co.,Inc | |||||||||||||
Full Title: A Phase III Study to Assess the Safety, Tolerability, and Efficacy of MK-0822 (Odanacatib) in Prolonging Bone Metastasis-Free Survival in Men with Castration-Resistant Prostate Cancer | |||||||||||||
Medical condition: Prevention of bone metastases in men with prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002119-42 | Sponsor Protocol Number: 0822-029 | Start Date*: 2008-09-23 | |||||||||||
Sponsor Name:Merck& Co., Inc. | |||||||||||||
Full Title: A Phase III Study to Assess the Tolerability and Efficacy of MK-0822 (Odanacatib) in Reducing the Risk of Bone Metastases and Prolonging Disease-Free Survival in Women with Breast Cancer Spanish t... | |||||||||||||
Medical condition: Prevention of disease recurrence in patients with breast cancer. Spanish indication: Prevención de recurrencia de la enfermedad en pacientes con cáncer de mama | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006195-11 | Sponsor Protocol Number: BC1-06 | Start Date*: 2008-03-26 | |||||||||||
Sponsor Name:Algeta ASA | |||||||||||||
Full Title: A double-blind, randomised, multiple dose, Phase III, multicentre study of Alpharadin in the treatment of patients with symptomatic hormone refractory prostate cancer with skeletal metastases. | |||||||||||||
Medical condition: Hormone refractory prostate cancer with skeletal metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: SE (Completed) FR (Completed) GB (Completed) BE (Completed) SK (Completed) ES (Completed) CZ (Completed) NL (Completed) IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004879-13 | Sponsor Protocol Number: UKF2013/12 | Start Date*: 2014-12-08 | |||||||||||||||||||||
Sponsor Name:Universitätsklinikum Freiburg | |||||||||||||||||||||||
Full Title: α-RT; Phase II open-label study to evaluate the efficacy and safety of Radium-223 dichloride in combination with external beam radiotherapy (EBRT) vs. EBRT alone in the treatment of advanced castr... | |||||||||||||||||||||||
Medical condition: Bone metastases in advanced castration resistant prostate carcinoma. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020174-42 | Sponsor Protocol Number: ZonMw11510009 | Start Date*: 2011-11-04 |
Sponsor Name:ZonMw | ||
Full Title: Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized study | ||
Medical condition: Bone metastases | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002114-36 | Sponsor Protocol Number: 20110113 | Start Date*: 2011-10-04 | |||||||||||||||||||||
Sponsor Name:Amgen Inc | |||||||||||||||||||||||
Full Title: Open-Label Access Protocol of Denosumab for Subjects with Advanced Cancer | |||||||||||||||||||||||
Medical condition: Bone Metastases in Subjects with Advanced Breast Cancer and Bone Metastases in Men with Hormone-Refractory Prostate Cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: HU (Completed) CZ (Completed) AT (Completed) FR (Completed) ES (Completed) PL (Completed) BE (Completed) LV (Completed) LT (Completed) IT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-001621-94 | Sponsor Protocol Number: 2007-1805 | Start Date*: 2007-08-11 | ||||||||||||||||
Sponsor Name:Lothian Health Board [...] | ||||||||||||||||||
Full Title: Pregabalin Bone Trial. A double-blind randomised controlled trial of pregabalin versus placebo in conjunction with palliative radiotherapy for malignant bone pain. | ||||||||||||||||||
Medical condition: The condition under investigation is cancer induced bone pain (CIBP). This is a major cause of morbidity in patients with cancer and unfortunately standard treatments (including radiotherapy) can b... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-000697-74 | Sponsor Protocol Number: ML20115 | Start Date*: 2006-08-07 |
Sponsor Name:The BONiFIN study group | ||
Full Title: A phase II, open label study to establish the safety and efficacy of intravenous loading dose of 3 x Bondronat 6 mg in 3 consecutive days in patients with breast cancer and skeletal metastases expe... | ||
Medical condition: Treatment of pain in breast cancer patients with bone metastases | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003441-16 | Sponsor Protocol Number: ML20570 | Start Date*: 2006-12-12 | |||||||||||
Sponsor Name:N.V. Roche S.A. | |||||||||||||
Full Title: OPEN LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS LOADING DOSE OF 3X 6MG IBANDRONIC ACID (BONDRONAT®) DURING 3 CONSECUTIVE DAYS IN PATIENTS WITH BREAST CANCER AND SKELETAL METASTA... | |||||||||||||
Medical condition: Metastasic bone pain in patients with breast cancer and bone metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002669-38 | Sponsor Protocol Number: 0822-016 | Start Date*: 2006-12-07 | |||||||||||
Sponsor Name:Merck & Co Inc. | |||||||||||||
Full Title: A Phase II Study to Assess the Safety, Tolerability, and Efficacy of MK-0822 (Cathepsin-K Inhibitor) in the Treatment of Women with Breast Cancer and Established Bone Metastases (MBD) | |||||||||||||
Medical condition: Metastatic Bone Disease (MBD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) NO (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001855-12 | Sponsor Protocol Number: BO 18040 | Start Date*: 2004-02-16 |
Sponsor Name:F. Hoffmann-La Roche Ltd | ||
Full Title: Randomized, two arm, placebo controlled study to compare the efficacy of IV loading doses followed by maintenance treatment with IV ibandronic acid versus zoledronic acid in patients with skeletal ... | ||
Medical condition: Metastatic Bone Pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) GB (Completed) DE (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-001854-10 | Sponsor Protocol Number: BO18039 | Start Date*: 2005-02-16 |
Sponsor Name:F. Hoffmann-La Roche Ltd | ||
Full Title: Randomized, two arm, placebo controlled double dummy study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in... | ||
Medical condition: Metastatic Bone Pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) GB (Completed) DE (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.